By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Ramsey  New Jersey    U.S.A.
Phone: Fax:



Start Up

Company News
Valeritas’ V-Go Device Shows To Help Improve Compliance And Efficacy For Patients With Diabetes On Insulin + GLP-1 Therapy As Well As Those Who Switched From Subcutaneous Insulin Injections To V-Go 10/23/2015 10:34:44 AM
Valeritas’ V-Go Disposable Insulin Delivery Device Demonstrates Efficacy And Safety In Patients With Diabetes 10/22/2015 9:32:28 AM
Real-World Study Data Demonstrating That Valeritas' V-Go Consistently Reduces A1C Levels And Decreases Insulin Requirements For Patients With Diabetes Regardless Of Baseline A1C Presented At American Diabetes Association 2015 6/8/2015 9:13:19 AM
Real-World Data From Three Separate Studies Demonstrate That Valeritas' V-Go Significantly Reduces A1c And Lowers Total Daily Insulin Dose For Patients With Diabetes 5/18/2015 10:25:11 AM
Study Shows That Valeritas' V-Go Improves Blood Glucose Control And Reduces Insulin Requirements In Residents Of Long Term Care Facilities 5/18/2015 7:30:30 AM
Study Analysis Shows Valeritas' V-Go Device Helps Reduce Diabetes Management Cost For Type 2 Diabetes Patients By Improving Glycemic Control And Reducing Insulin Doses 4/10/2015 10:58:28 AM
Insulin Delivery Device Maker Valeritas Postpones $75 Million IPO 3/26/2015 9:39:47 AM
Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 10/20/2014 8:57:14 AM
Type 2 Insulin Pump Maker Valeritas Eyes $45 Million 7/8/2014 7:20:43 AM
Interim Analysis Suggests That Delivery Of Insulin Via Valeritas' V-Go® Shows Promise In Improving Glycemic Control For Patients With Type 2 Diabetes Previously Taking Long-Acting Insulin 5/16/2014 8:59:52 AM